Burning Rock Biotech (BNR) director Wendy W. Hayes files initial Form 3

Rhea-AI Filing Summary

Burning Rock Biotech Ltd director Wendy W. Hayes filed an initial Form 3, which is a statement of beneficial ownership for company insiders. This filing establishes her status as a director and indicates that no insider transactions or derivative positions are reported in this submission.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hayes Wendy W.

(Last) (First) (Middle)

12271 MONUMENT HILL AVE

(Street)

LAS VEGAS NV 89138

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/17/2026

3. Issuer Name and Ticker or Trading Symbol
Burning Rock Biotech Ltd [ BNR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 (Power of Attorney)

No securities are beneficially owned.

	/s/ Yuheng Huang, Attorney-in-Fact for Hayes Wendy	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Burning Rock Biotech (BNR) Form 3 filing for Wendy W. Hayes show?

The Form 3 for Burning Rock Biotech director Wendy W. Hayes reports her initial beneficial ownership status. It records her as a director and shows no reported insider transactions, derivative positions, or holdings data in this specific filing.

Does the BNR Form 3 for Wendy W. Hayes report any insider stock purchases or sales?

No, the Form 3 for Wendy W. Hayes reports zero insider stock purchases or sales. The transaction summary shows no buy, sell, acquisition, disposition, or derivative transactions associated with her in this particular filing.

What insider role does Wendy W. Hayes have at Burning Rock Biotech (BNR)?

Wendy W. Hayes is reported as a director of Burning Rock Biotech. The Form 3 indicates she is not an officer and not a ten percent owner, formally documenting her status as a board-level insider for regulatory purposes.

Are there any derivative securities reported for Wendy W. Hayes in the BNR Form 3?

No derivative securities are reported for Wendy W. Hayes in this Form 3. The derivative summary is empty, and the filing shows no option, warrant, or other derivative positions disclosed for her at this time.

Does the Burning Rock Biotech (BNR) Form 3 include any footnote restrictions for Wendy W. Hayes?

The Form 3 data includes a placeholder for footnotes but no substantive footnote text. There are no disclosed comments about voting power, investment authority, or special ownership arrangements for Wendy W. Hayes in this excerpt.